Evidence map›Paper›PMID 36028820›Full record

ArticleBMC neurology2022

Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis.

Dominik Stelzle, Joyce Kaducu, Veronika Schmidt, Tamara M Welte, Bernard J Ngowi, William Matuja, Gabrielle Escheu, Peter Hauke, Vivien Richter, Emilio Ovuga and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 7 countries.

Dominik StelzleCenter for Global Health, Department of Neurology, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany.ORCID http://orcid.org/0000-0001-6743-2818
Joyce KaducuMinistry of Health, Kampala, Republic of Uganda.
Veronika SchmidtCenter for Global Health, Department of Neurology, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany.
Tamara M WelteCenter for Global Health, Department of Neurology, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany.
Bernard J NgowiNational Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
William MatujaDepartment of Neurology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Gabrielle EscheuDepartment of Neurology, Kliniken Ostallgaeu-Kaufbeuren, Kaufbeuren, Germany.
Peter HaukeDepartment of Neurology, Kliniken Ostallgaeu-Kaufbeuren, Kaufbeuren, Germany.
Vivien RichterDepartment of Radiology, University Hospital Tuebingen, Tuebingen, Germany.
Emilio OvugaDepartment of Mental Health, University of Gulu, Gulu, Uganda.
Bettina PfauslerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Erich SchmutzhardDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Action AmosNational Epilepsy Association Malawi, International Bureau of Epilepsy, Lilongwe, Malawi.
Wendy HarrisonDepartment of Infectious Disease Epidemiology, Imperial College London, London, UK.
Luise KellerDepartment of Neurology, School of Medicine, Technical University of Munich, Munich, Germany.
Andrea S WinklerCenter for Global Health, Department of Neurology, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany. andrea.winkler@tum.de.ORCID http://orcid.org/0000-0003-3131-6983
Innsbruck Medical University · ATTechnical University of Munich · DEUniversity of Oslo · NOChristian Health Association of Malawi · MWGulu University · UGImperial College London · GBMbeya University of Science and Technology · TZMinistry of Health · UGMuhimbili University of Health and Allied Sciences · TZUniversitätsklinikum Erlangen · DEUniversity of Tübingen · DE

Funding

Bill and Melinda Gates Foundation 1017886Deutsche Forschungsgemeinschaft WI 3427/1-1
6 · The paper itself

Abstract

backgroundEpilepsy is one of the most common neurological disorders worldwide. Yet, its treatment gap is large in some areas and especially in sub-Saharan Africa data on clinical, radiological and semiological characteristics, as well as on treatment of persons with epilepsy (PWE) are still scarce.

methodsWe pooled data from four cross-sectional studies on epilepsy in eastern Africa. Two studies from Malawi and Uganda were community-based; two studies in Tanzania (urban Dar es Salaam and rural Haydom) were hospital-based. Clinical characteristics of PWE were assessed by the same questionnaire. Additionally, data on treatment were collected and computed tomography (CT) scans were performed.

resultsOverall, 1179 PWE were included in our analysis (581 (49.3%) female, median age 22 years (IQR 15-32 years)). Up to 25% of the patients had focal onset seizures. Those showed a higher rate of remarkable CT scan findings, with especially post-ischaemic and neurocysticercosis-associated lesions, compared to PWE with generalized onset seizures (35.1% vs. 20%). The majority of the patients experienced tonic-clonic seizures (70-85%). Only 67-78% of PWE received anti-seizure medication (ASM) treatment in the community-based studies, mostly monotherapy with phenobarbital, phenytoin or carbamazepine. Yet, underdosage was frequent and a large proportion of PWE received alternative non-ASM treatment consisting of herbal treatment (up to 83%) and/or scarification (up to 20%).

conclusionsEpilepsy is common in sub-Saharan Africa, often caused by neurocysticercosis or ischaemic strokes. PWE suffer from high seizure rates and subsequent injuries, as well as from socio-economic consequences due to insufficient ASM treatment. This pooled analysis illustrates the need for structural programmes for adequate identification, education, assessment and treatment of PWE in sub-Saharan Africa.

Indexed as

EpilepsyNeurocysticercosisAdultAnticonvulsantsCarbamazepineCross-Sectional StudiesFemaleHumansMaleSeizuresTanzaniaYoung AdultAnticonvulsantsCarbamazepineEpilepsyGlobal healthSub-Saharan AfricaTreatment gap

Identifiers

PMID36028820
PMCPMC9414166
OpenAlexW4293199898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.